Verapamil Hydrochloride

规格

152-11-4CAS 号

205-800-5EC 号

2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile;hydrochlorideIUPAC 名称

C27H39ClN2O4化学式

491.1 g/mol分子量

Verapamil hydrochloride; 152-11-4; Verapamil HCl; Verelan; Covera; Isoptin SR; Verelan PM; Calan SR; DTXSID2034095; NSC-272366; NSC-657799; V3888OEY5R; Verapamili hydrochloridum; NSC657799; LU-20175; (+-)-Verapamil hydrochloride; DTXCID0014095; NSC272366; Securon mid; Manidon sr; Ranvera mr; Securon iv; Securon sr; Half securon sr; Vera-til sr; Cordilox i.v.; Cordilox mr 240; Ethimil mr 240; Verapress mr 240; Vertab sr 240; VERAPAMIL HCI; RefChem:56207; CHEBI:53188; (2RS)-5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)pentanenitrile monohydrochloride; 205-800-5; 23313-68-0; Berkatens; Cordilox; Calan; (+/-)-VERAPAMIL HYDROCHLORIDE; Calcan hydrochloride; Isoptin; Geangin; Izoptin; Veratensin; Univer; Verapamyl hydrochloride; Covera-HS; Verapamil (hydrochloride); 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxy phenyl)-2-isopropylvaleronitrile hydrochloride; MFCD00055208; C27H39ClN2O4; verapamil.hcl; MLS000069485; 5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrile hydrochloride; SMR000059109; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile hydrochloride; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile;hydrochloride; 5-[N-(3,4-Dimethoxyphenylethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile hydrochloride; ( inverted exclamation markA)-Verapamil hydrochlorid; Verapamil chloridrate; D-365 hydrochloride; Iproveratril hydrochloride; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile hydrochloride; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl]methylamino}-2-(methy lethyl)pentanenitrile, chloride; SR-01000000050; EINECS 205-800-5; NSC 272366; UNII-V3888OEY5R; LU 20175; Prestwick_440; Vasolan (TN); Verelan (TN); Covera-hs (TN); Calan (TN); Isotopin hydrochloride; Verapamil hydrochloride [USAN:USP:JAN]; Opera_ID_1210; Verapamil hydrochloride RS; CAS-152-11-4; (?-Verapamil hydrochloride; Verapamil hydrochloride CRS; (y)-Verapamil hydrochloride; (?)-Verapamil hydrochloride; CHEMBL1280; SCHEMBL33296; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile monohydrochloride; Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride; MLS001055442; MLS002222213; SPECTRUM2300307; ( inverted exclamation markA)-Verapamil hydrochloride; orb1226158; orb1310060; ARD10701A; HY-A0064R; MSK10701A; GLXC-07742; HMS1568M04; HMS1922J16; HMS5082J10; Pharmakon1600-02300307; Verapamil HCl - Bio-X trade mark; (+/-)-Verapamil hydrochloride D7; 2-(3,4-Dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile--hydrogen chloride (1/1); HY-A0064; Tox21_201180; Tox21_501237; VERAPAMIL HYDROCHLORIDE [MI]; CCG-39491; EBC-12798; HB1237; NSC759589; s4202; Verapamil (hydrochloride) (Standard); Verapamil hydrochloride (JP18/USP); VERAPAMIL HYDROCHLORIDE [JAN]; VERAPAMIL HYDROCHLORIDE [HSDB]; VERAPAMIL HYDROCHLORIDE [USAN]; AKOS005267117; AC-8483; CS-1685; FV28686; LP01237; NSC-759589; VERAPAMIL HYDROCHLORIDE [MART.]; VERAPAMIL HYDROCHLORIDE [VANDF]; VERAPAMIL HYDROCHLORIDE [USP-RS]; VERAPAMIL HYDROCHLORIDE [WHO-DD]; VERAPAMIL HYDROCHLORIDE [WHO-IP]; NCGC00024710-03; NCGC00094479-01; NCGC00094479-02; NCGC00094479-03; NCGC00094479-04; NCGC00094479-05; NCGC00258732-01; NCGC00261922-01; (+-)-5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile monohydrochloride; AC-16228; AS-16018; Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride, (+-)-; BV164516; ST066908; SY073165; Valeronitrile, 5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropyl-, monohydrochloride; EU-0101237; NS00079093; SW196662-4; V0118; V1769; VERAPAMIL HYDROCHLORIDE [EP IMPURITY]; VERAPAMIL HYDROCHLORIDE [ORANGE BOOK]; TARKA COMPONENT VERAPAMIL HYDROCHLORIDE; VERAPAMIL HYDROCHLORIDE [EP MONOGRAPH]; D00619; D78147; D88195; EN300-124002; V 4629; VERAPAMIL HYDROCHLORIDE [USP MONOGRAPH]; ( inverted question mark)-Verapamil hydrochloride; VERAPAMILI HYDROCHLORIDUM [WHO-IP LATIN]; F047206; Verapamil.HCl, 1mg/ml in Methanol (as free base); SR-01000000050-2; SR-01000000050-4; Q27291481; SR-01000000050-11; Z1557407143; (+/-)-Verapamil hydrochloride, >=99% (titration), powder; Verapamil Hydrochloride 1.0 mg/ml in Methanol (as free base); Verapamil hydrochloride, European Pharmacopoeia (EP) Reference Standard; Verapamil hydrochloride, United States Pharmacopeia (USP) Reference Standard; (+/-)-5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile monohydrochloride; (+/-)-Verapamil hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; ?-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-?-(1-methylethyl)-benzeneacetonitrile hydrochloride; 2-(3,4-Dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)-ethyl](methyl)amino]-2-isopropylpentanenitrile hydrochloride; 5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrilehydrochloride; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile Hydrochloride; alpha-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl) benzeneacetonitrile hydrochloride; alpha-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile hydrochloride (1:1); BENZENEACETONITRILE, .ALPHA.-(3-((2-(3,4-DIMETHOXYPHENYL)ETHYL)METHYLAMINO)PROPYL)-3,4-DIMETHOXY-.ALPHA.-(1-METHYLETHYL)-, MONOHYDROCHLORIDE, (+/-)-; Benzeneacetonitrile,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-.alpha.-(1-methylethyl)-, monohydrochloride同义词